Effects of dopamine β-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice

2005/09/14 by Brooke N. Bourdélat-Parks, George M. Anderson, Zoe R. Donaldson +6 · 25 citations
Neuroscience · Medicine · #Neurotransmitter Receptor Influence on Behavior #Stress Responses and Cortisol #Alcohol Consumption and Health Effects

paper · doi:10.1007/s00213-005-0139-8

Citations

• Human genetics of plasma dopamine ?-hydroxylase activity: applications to research in psychiatry and neurology

Cited by

• Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine. [europepmc]
• Norepinephrine signaling through beta-adrenergic receptors is critical for expression of cocaine-induced anxiety. [europepmc]
• Behavioral responses of dopamine beta-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action. [europepmc]
• Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. [europepmc]
• Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase. [europepmc]
• Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease. [europepmc]
• Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice. [europepmc]
• Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase. [europepmc]
• The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study. [europepmc]
• Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease. [europepmc]
• ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse. [europepmc]
• Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation. [europepmc]
• Regulatory polymorphisms in human DBH affect peripheral gene expression and sympathetic activity. [europepmc]
• Norepinephrine is necessary for experience-dependent plasticity in the developing mouse auditory cortex. [europepmc]
• A review of pharmacogenetic studies of substance-related disorders. [europepmc]
• Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system. [europepmc]
• Noradrenergic regulation of plasticity marker expression in the adult rodent piriform cortex. [europepmc]
• Downregulation of the Central Noradrenergic System by Toxoplasma gondii Infection. [europepmc]
• Pharmacogenetic role of dopamine transporter (SLC6A3) variation on response to disulfiram treatment for cocaine addiction. [europepmc]
• Dissociable Catecholaminergic Modulation of Visual Attention: Differential Effects of Catechol-O-Methyltransferase and Dopamine Beta-Hydroxylase Genes on Visual Attention. [europepmc]
• Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus. [europepmc]
• Noradrenergic circuits in the forebrain control affective responses to novelty. [europepmc]
• Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer's disease. [europepmc]
• Treatment With Nepicastat Decreases Contextual Traumatic Memories Persistence in Post-traumatic Stress Disorder. [europepmc]
• Norepinephrine and dopamine contribute to distinct repetitive behaviors induced by novel odorant stress in male and female mice. [europepmc]